A Coruña

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer2 trials
• HIV1 trial
• Lung cancer1 trial
• Lupus (SLE)1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Terminated1 trial

Lead sponsor

• GlaxoSmithKline2 trials
• Tesaro, Inc.2 trials
• ViiV Healthcare1 trial

Running trials

• Active, not recruiting

  A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

  NCT06472076· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

  NCT02938520· Phase 3· ViiV Healthcare· Source

Closed trials

• Terminated

  A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)

  NCT06964165· Phase 2· Tesaro, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer

  NCT03574779· Phase 2· Tesaro, Inc.· Source

• Completed

  Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

  NCT01729455· GlaxoSmithKline· Source